Product Information

FONDAPARINUX 7.5 MG/0.6 ML SYR is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $41.5808 per ML under NDC 55111068010. Its NADAC has been published 634 times since Nov 28, 2013.

FDA first approved this application on Jul 11, 2011. Its Orange Book therapeutic-equivalence code is AP.

FONDAPARINUX 7.5 MG/0.6 ML SYR

Fondaparinux Sodium
$41.5808per ML

Strength

7.5 mg/.6mL

NDC

55111068010

Classification

Generic

Dosage Form

INJECTION

Route

SUBCUTANEOUS

Effective Date

11/18/2026

Active Ingredients

FONDAPARINUX SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA091316

FDA Approved

7/11/2011

TE Code

AP

On Market Since

7/14/2011

Pharmacological Classes

Factor Xa Inhibitor
Factor Xa Inhibitors

Price Statistics

The NADAC for FONDAPARINUX 7.5 MG/0.6 ML SYR has been published 634 times since Nov 28, 2013, and over the history we have for it it has declined 69.0%. The table below summarizes its recorded NADAC range and movement.

Current price$41.5808 per ML
All-time high$142.7144 (Apr 15, 2015)
All-time low$34.9283 (Jun 19, 2024)
52-week high$43.4533
52-week low$39.1987
Median price$68.7043
Average price$75.2195
Largest weekly change-30.5% (Jul 20, 2016)
Weeks tracked634
Tracking sinceNov 28, 2013

Price History

1W

-1.8%

1M

-2.9%

3M

-2.6%

6M

-4.1%

1Y

+6.1%

3Y

-25.3%

5Y

-39.5%

All

-69.0%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 50% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of FONDAPARINUX 7.5 MG/0.6 ML SYR?

The current National Average Drug Acquisition Cost (NADAC) for FONDAPARINUX 7.5 MG/0.6 ML SYR, manufactured by Dr. Reddy's Laboratories Inc., is $41.5808 per ML (NDC 55111068010), effective Nov 18, 2026.

How has the price of FONDAPARINUX 7.5 MG/0.6 ML SYR changed over time?

Over the history we have for it, the NADAC for FONDAPARINUX 7.5 MG/0.6 ML SYR has declined 69.0%. It has been tracked across 634 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for FONDAPARINUX 7.5 MG/0.6 ML SYR?

Since Nov 28, 2013, the NADAC for FONDAPARINUX 7.5 MG/0.6 ML SYR has ranged from a low of $34.9283 (Jun 19, 2024) to a high of $142.7144 (Apr 15, 2015), with a median of $68.7043 per ML.

Are there cheaper alternatives to FONDAPARINUX 7.5 MG/0.6 ML SYR?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FONDAPARINUX 7.5 MG/0.6 ML SYR, is $20.9233 per ML — about 50% below FONDAPARINUX 7.5 MG/0.6 ML SYR.

Who manufactures FONDAPARINUX 7.5 MG/0.6 ML SYR?

FONDAPARINUX 7.5 MG/0.6 ML SYR (NDC 55111068010) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.